Pharma feed

N
Amgen, Inc
Law 360· 22 Jun 2021

High Court Skips Amgen Unit's Arthrex Arguments In IP Case

Law360 (June 21, 2021, 5:37 PM EDT) -- The U.S. Supreme Court refused Monday to review whether an Amgen Inc. unit's patent on treating inflammatory disorders was improperly struck down, despite arguments that the invalidation was decided by unconstitutionally appointed judges under the Arthrex ruling.

  • Amgen, Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Teva Pharmaceutical Industries Ltd
Bloomberg Law· 22 Jun 2021

Teva to Settle Mississippi Drug-Price Case, Seek More Pacts

Teva Pharmaceutical Industries Ltd. said it had agreed to pay the state of Mississippi $925,000 to resolve claims that the company fixed prices of generic drugs, and that it is discussing potential pacts with other states.

  • Teva Pharmaceutical Industries Ltd
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Cadila Healthcare Ltd
The Times of India· 22 Jun 2021

Bayer, Zydus extend pharma JV by 3 years

Mumbai: German chemical and pharma major Bayer and Ahmedabad-based Cadila Healthcare on Monday extended their pharmaceuticals joint venture by three years from June 2021. The companies first entered into an agreement in January 2011 to set up Bayer Zydus Pharma for sales and marketing of pharmaceuticals in the country, the company said.During the term of the joint venture, the company launched Bayer’s global assets including Xarelto, Eylea and Visanne.

  • Bayer Zydus Pharma
  • Cadila Healthcare Ltd
  • Bayer AG
  • Partnerships and Alliances
  • News Articles
  • News Websites
N
Exelixis Inc
MarketScreener· 22 Jun 2021

EXELIXIS, INC. : Change in Directors or Principal Officers (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously announced by Exelixis, Inc. ("Exelixis"), effective June 18, 2021 , Gisela M. Schwab , M.D., President, Product Development and Medical Affairs and Chief Medical Officer of Exelixis , began a medical leave of absence.

  • Exelixis Inc
  • Management Changes
  • News Articles
  • News Websites
N
Merck & Co., Inc.
MarketScreener· 22 Jun 2021

Merck : CONSOLIDATED STATEMENT OF INCOME - GAAP (Form 8-K)

(1) Because the company recorded a net loss in the fourth quarter of 2020, no potential dilutive common shares were used in the computation of loss per common share assuming dilution as the effect would have been anti-dilutive.

  • Merck & Co., Inc.
  • Financial Results
  • News Articles
  • News Websites
N
Bayer AG
Brantfordexpositor· 22 Jun 2021

New Roundup lawsuit filed

Article content Legal firm Grant & Eisenhofer has filed a lawsuit in California against Bayer’s Roundup herbicide, claiming its client Michael Langford of the Sacramento area developed cancer after using Roundup. The lawsuit follows the collapse in court of an offer Bayer made to compensate clients who claim illnesses arising from exposure to Roundup.

  • Bayer AG
  • Regulatory and Legal
  • Negative News
  • News Articles
  • News Websites
N
Merck & Co., Inc.
MarketScreener· 22 Jun 2021

MERCK & CO., INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure. On June 2, 2021 , Merck & Co., Inc. ( Merck ) completed the spinoff of products from its women's health, biosimilars and established brands businesses into a new, independent, publicly traded company named Organon & Co. (Organon) through a distribution of Organon's publicly traded stock to Merck shareholders.

  • Merck & Co., Inc.
  • Regulatory and Legal
  • News Articles
  • News Websites
N
AstraZeneca PLC
Billboard· 22 Jun 2021

'Springsteen on Broadway' Does About Face on AstraZeneca Vaccine

The WHO oversees international public health standards and recommendations for the United Nations. When The Boss announced his new run of dates this summer -- 31 in total between June 26 to Sept. 4 -- it specified that only people fully vaccinated with FDA-approved vaccines would be allowed to attend.

  • AstraZeneca PLC
  • Regulatory and Legal
  • News Articles
  • News Websites
N
AstraZeneca PLC
The Canberra Times· 22 Jun 2021

Moderna to submit application for COVID-19 vaccine to Therapeutic Goods Administration

coronavirus, Moderna is expected to submit a "comprehensive" application for approval of its COVID-19 vaccine to the Therapeutic Goods Administration next month. If the vaccine gains approval, it would become the third COVID-19 vaccine on offer in Australia alongside AstraZeneca and Pfizer.

  • AstraZeneca PLC
  • Therapeutic Goods Administration
  • Regulatory and Legal
  • News Articles
  • News Websites
N
KiWi Power
Tvnz· 22 Jun 2021

Morning Briefing June 22: New vaccine milestone as children approved for jab

Kiwi children will soon be eligible for a Covid vaccine, the travel bubble with Victoria gets ready to fly again, and the All Blacks name four debutants and a new captain in their latest squad. A teenager receives a Pfizer vaccine - file photo.

  • KiWi Power
  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Pfizer Inc
Daily Pakistan· 22 Jun 2021

Pakistan signs agreement to buy 13 million Pfizer doses

ISLAMABAD — Pfizer Pakistan and BioNTech on Monday announced an agreement with the National Disaster Management Authority (NDMA) to supply 13 million doses of their Covid-19 vaccine (BNT162b2) to Pakistan.

  • Pfizer Inc
  • Procurement and Sales
  • News Articles
  • News Websites
N
Pfizer Inc
Australian Broadcasting Corporation· 22 Jun 2021

New Zealand's medical regulator gives provisional approval for Pfizer to be given to 12- to 15-year-olds

The New Zealand medical regulator has gives its provisional approval for the Pfizer vaccine to be given to teenagers aged 12 to 15 years.

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
N
AstraZeneca PLC
The Sun Daily· 21 Jun 2021

Expand types of pop-up vaccine centres

ALTHOUGH it is a good sign more than one million people registered their interest voluntarily on May 26, the second phase of the AstraZeneca vaccination is only scheduled between June 7 and July 27. This is only applicable for those who have taken the first dose of the vaccine.

  • AstraZeneca PLC
  • Business Expansion
  • News Articles
  • News Websites
N
Pfizer Inc
MSN Australia· 21 Jun 2021

Dr. Scott Gottlieb worries about spread of delta Covid variant among kids in schools this fall

Dr. told CNBC on Monday the highly transmissible delta Covid variant, first discovered in India, could present challenges to U.S. schools this fall given lower vaccination rates among children. "I think the reality is that kids are becoming more likely to be vectors of these new variants," the former Food and Drug Administration commissioner said on It's only been a little more than a month since the FDA cleared Pfizer's Covid vaccine for .

  • Pfizer Inc
  • US Food and Drug Administration
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Pfizer Inc
Umbc· 21 Jun 2021

On-Campus COVID-19 Vaccine Clinic

We will be administering the first shot of the Pfizer vaccine in partnership with Albertson’s/Safeway. You can sign up for your June 22 on-campus appointment . Participants will be able to schedule their second shot at Safeway locations or other providers.

  • Pfizer Inc
  • University of Maryland-Baltimore County
  • Safeway Inc
  • Events
  • News Articles
  • News Websites
N
AstraZeneca PLC
Thefirstnews· 21 Jun 2021

More Covid-19 vaccines arrive in Poland on Monday

Christian Charisius/PAP/EPA A supply of 2.6 million Pfizer/BioNTech vaccines and 324,000 AstraZeneca vaccines have reached Poland, the head of the government's Strategic Reserves Agency told PAP on Monday. On Sunday, Michał Kuczmierowski had informed PAP that 122,000 Johnson & Johnson vaccines would reach Poland on Tuesday, and that 285,000 Moderna vaccines would arrive on Saturday.

  • AstraZeneca PLC
  • Regulatory and Legal
  • News Articles
  • News Websites
N
RealPage, Inc.
GuruFocus· 21 Jun 2021

Melqart Asset Management (UK)

Investment company Current Portfolio ) buys RealPage Inc, Alexion Pharmaceuticals Inc, , PowerShares QQQ Trust Ser 1, Pluralsight Inc, sells , , Navistar International Corp, Fitbit Inc, during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Melqart Asset Management (UK) Ltd. As of 2021Q1, Melqart Asset Management (UK) Ltd owns 140 stocks with a total value of $2.2 billion.

  • RealPage, Inc.
  • Alexion Pharmaceuticals Inc
  • Investment Company plc
  • M&A Activities
  • News Articles
  • News Websites
N
Pfizer Inc
Citybeat· 21 Jun 2021

Here’s What to Know About COVID-19 Vaccine Booster Shots

Photo: spencerbdavis1, Pixabay Roughly six months ago, on Dec. 11, the Food and Drug Administration (FDA) authorized the first COVID-19 vaccine for emergency use in the United States. What followed was a push to get that shot, developed by Pfizer and BioNTech, to those at high risk (SN: 12/1/20).

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Amgen, Inc
Bloomberg Law· 21 Jun 2021

Amgen Loss in Sanofi Fight Over Praluent Will Stand, Court Says

The U.S. Court of Appeals for the Federal Circuit declined to reconsider a February decision that two Amgen patents on a cholesterol treatment are invalid.

  • Amgen, Inc
  • Sanofi
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Forks Inc.
Grand Forks Herald· 21 Jun 2021

Where to find the mobile COVID-19 vaccine clinic in Grand Forks this week

Grand Forks Public Health will host more mobile COVID-19 vaccination clinics this week in collaboration with Wall's Medicine Center and WelCore Personal Corporate Health. These clinics will offer the one-dose Johnson & Johnson vaccine, so individuals will not need to return for second-dose shots, according to a release from GFPH.

  • Forks Inc.
  • Johnson & Johnson
  • Events
  • News Articles
  • News Websites
N
Takeda Pharmaceutical Co Ltd
Twitter· 21 Jun 2021

Takeda’s President of R&D Andy Plump will emcee the 15th Annual @USAIC BioPharma & Healthcare Summit on June 22. He will also be participating in an afternoon panel discussing strategies and trends in R&D. To register for the virtual summit, click here: https://t.co/1bDEtlv9xS

Takeda’s President of R&D Andy Plump will emcee the 15th Annual @USAIC BioPharma & Healthcare Summit on June 22. He will also be participating in an afternoon panel discussing strategies and trends in R&D. To register for the virtual summit, click here: https://t.co/1bDEtlv9xS

USA India Chamber of commerce
15th Annual BioPharma & Healthcare Summit, Tuesday, June 22, 2021 - Virtual Event 8 AM EST to 3:30 PM EST In these unprecedented times due to COVID-19, USAIC is offering Free Regi…
  • Takeda Pharmaceutical Co Ltd
  • Events
  • Social Updates
  • Social Media
N
Johnson & Johnson
IOL· 21 Jun 2021

WCED plans to start its vaccination roll-out on Friday

The Western Cape Education Department (WCED) announced that it plans to begin its vaccination roll-out of teachers and school staff on Friday. On Monday, the WCED said it had been approved to receive additional doses of the Johnson & Johnson (J&J) single dose vaccine and it was planning to start its roll-out programme on Friday, June 25.

  • Johnson & Johnson
  • New Offerings
  • News Articles
  • News Websites
N
Takeda Pharmaceutical Co Ltd
Twitter· 21 Jun 2021

A new report highlights the barriers impeding collection of human plasma in Europe and the urgent need for solutions to enable a sustainable supply for patients who rely on plasma-derived therapies. Read the report here: https://t.co/VZ9YSLEz6X

A new report highlights the barriers impeding collection of human plasma in Europe and the urgent need for solutions to enable a sustainable supply for patients who rely on plasma-derived therapies. Read the report here: https://t.co/VZ9YSLEz6X

New report: The impact of plasma-derived therapies in Europe
More than a million patients in Europe suffer from one of the 12 most recognized rare diseases, which can all be treated with plasma-derived therapies (PDTs). Treatment with PDTs …
  • Takeda Pharmaceutical Co Ltd
  • ESG
  • Social Updates
  • Social Media
N
AstraZeneca PLC
The Scottish Sun· 21 Jun 2021

Four Brits develop life-threatening condition days after having Covid jab

FOUR Brits have developed a life threatening condition days after having the AstraZeneca coronavirus jab, doctors have revealed. The cases of Guillain-Barré Syndrome developed more than ten days after the patients received the jab and were all after the first dose - but doctors say it's unlikely the jabs triggered the condition.

  • AstraZeneca PLC
  • New Offerings
  • News Articles
  • News Websites
N
Bayer AG
MarketScreener· 21 Jun 2021

Bayer : Germany's BaFin looking into possible insider trading of CureVac shares

BaFin will investigate whether employees at Curevac or Bayer could have used their insider knowledge of the vaccine study results and sold shares in good time, the newspaper added. Shares in CureVac droped more than 50% on Thursday following the company's announcement, erasing more than 6 billion euros ($7.2 billion) from the company's market value.

  • BaFin
  • Bayer AG
  • Negative News
  • News Articles
  • News Websites
1 2 3 4 5